Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Arzneimittel-Forschung|July 1, 1997
Pharmacokinetics of estradiol and of estrone during application of three strengths of an estradiol transdermal patch with active matrixI Setnikar, L C Rovati, J J Thebault, et al.Maturitas|November 1, 1996
Comparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50). II. Local skin tolerabilityH Rozenbaum, M Birkhäuser, C De Nooyer, et al.European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1991
Pharmacokinetics of pyrimethamine in healthy young volunteers using a new solid phase extraction/HPLC methodA Le Liboux, H Duquesne, G Montay, et al.Psychopharmacology|February 1, 1994
EEG profile of intravenous zolpidem in healthy volunteersA Patat, S Trocherie, J J Thebault, et al.Clinical Drug Investigation|August 14, 2016
Bioavailability Study of Menorest®, a New Estrogen Transdermal Delivery System, Compared with a Transdermal Reservoir SystemY Le Roux, M L Borg, M Sibille, et al.Drugs|January 1, 1991
Comparative bioavailability study of cefixime administered as tablets or aqueous solutionG Montay, F Masala, Y Le Roux, et al.Journal of Clinical Pharmacology|November 1, 1994
Pharmacokinetics of sparfloxacin in humans after single oral administration at doses of 200, 400, 600, and 800 mgG Montay, R Bruno, J C Vergniol, et al.Journal of Pharmaceutical and Biomedical Analysis|September 1, 1992
Pharmacokinetics of 2-(alpha-thenoylthio)-propionylglycine (TTPG) in healthy volunteers--an oral dose-proportionality investigationA Marzo, G Bruno, D Nava, et al.Arzneimittel-Forschung|January 1, 1980
Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administrationG Bianchetti, C Blatrix, R Gomeni, et al.The American Journal of Cardiology|June 20, 1989
Pharmacokinetics of nicorandilA M Frydman, P Chapelle, H Diekmann, et al.Pageof 4